ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Meeting Management Challenges in axSpA

Thomas R. Collins  |  November 1, 2025

Axial Juvenile Spondyloarthritis

Dr. Weiss

Pamela Weiss, MD, clinical research director of the Rheumatology Division at Children’s Hospital of Philadelphia, reviewed some of the subtleties and challenges in axial juvenile spondyloarthritis (axJSpA).

It’s helpful to think of axJSpA as having a rule of 20, she said. About 20% of SpA is juvenile onset, about 20% of juvenile idiopathic arthritis (JIA) is JSpA, about 20% of JSpA cases involve axial disease, and about 20% of JSpA cases fail to achieve remission within five years.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Weiss cautioned that, when reading pediatric MRI images of the sacroiliac joint, a bright signal often does not indicate disease; the maturing SI joint tends to appear this way. A handy way to tell the difference, she said, is that if it looks like the whiteness around the edge of the joint could have been neatly drawn in with a Sharpie pen, “it’s probably just maturational signal.”

AxJSpA classification criteria published last year include seven domains with two or three levels in each domain, scored on a scale of 100, with 55 the threshold for a diagnosis.2 MRI findings are given the most weight in the scoring, and an online calculator is available, Dr. Weiss said.3

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Key differences between the juvenile and the adult criteria are that back, hip or groin pain can satisfy the requirements for juveniles, but only back pain is relevant in the adult criteria because young people can often have different ways of describing their pain, she said. Also, among juveniles, both imaging and clinical criteria must be met, rather than either one for adults.

Treatment options are much more limited for the JSpA population, Dr. Weiss noted. Research has also found that juvenile onset of axSpA tends to lead to fewer functional issues with the spine as people age, compared with adult-onset disease, but more hip functional issues compared with adult-onset disease.4

Mimics of axSpA

Dr. Gensler

Dr. Gensler

Lianne Gensler, MD, director of the University of California, San Francisco Ankylosing Spondylitis Clinic, drew attention to the many mimics that can initially appear to be possible axSpA.

Pregnancy is an important contributor to mimics of sacroiliitis, Dr. Gensler said. Women can have bone marrow edema from stress fractures during pregnancy that can persist for a year after they’ve given birth, but it might appear to be sacroiliitis. Low-dose computed tomography scans can provide additional clarity that can be highly useful. “Just interpret those [imaging] results with caution because it may be sacroiliitis, but it could also just be the pregnancy-related changes,” she noted. Osteitis condensans ilii and degenerative disease are two axSpA mimics that can be brought on by pregnancy.

Page: 1 2 3 | Single Page
Share: 

Filed under:ACR ConvergenceAxial SpondyloarthritisConditionsMeeting Reports Tagged with:ACR Convergence 2025ACR Convergence 2025 - PsAaxial juvenile spondyloarthritisaxial spondyloarthritis (SpA)

Related Articles
    Andrew Brookes / Image Source on Offset

    Clinical Insights into Axial Spondyloarthritis: Rheumatology Drugs at a Glance, Part 5

    February 10, 2022

    Over the past few years, biosimilars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options; others have few or only off-label options. This series, Rheumatology Drugs at a Glance, provides streamlined information on the administration of biologic, biosimilar and other medications used to…

    Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

    May 1, 2014

    New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation

    Top Research in Axial Spondyloarthritis Presented at ACR Convergence 2022

    November 18, 2022

    PHILADELPHIA—Approximately 100 research abstracts on axial spondyloarthritis (axSpA) were accepted for presentation at ACR Convergence 2022. It is exciting to see a wealth of research on axSpA being undertaken worldwide. Here, we highlight important points from 10 of these studies. 1. Abstract 0378: Prevalence of Axial Spondyloarthritis (axSpA) in Patients Treated for Chronic Back Pain…

    Key Research in Axial Spondyloarthritis Encapsulated

    December 2, 2024

    Our understanding of (axSpA) has really changed, especially with regard to male-female differences. In this report, we identify important research on axSpA presented at ACR Convergence 2024, summarize the abstracts and comment on why each is important, addressing the relevance for clinicians and the potential impact on future research.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences